about
CT-based attenuation correction in I-123-ioflupane SPECTPETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.Performance evaluation of stationary and semi-stationary acquisition with a non-stationary small animal multi-pinhole SPECT system.Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.Mental speed is associated with the shape irregularity of white matter MRI hyperintensity load.Brain perfusion imaging under acetazolamide challenge for detection of impaired cerebrovascular reserve capacity: positive findings with O-15-water PET in patients with negative Tc-99m-HMPAO SPECT.Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy.Global scaling for semi-quantitative analysis in FP-CIT SPECT.Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls.Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.Preserved brain metabolic activity at the age of 96 years.Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation.Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment.Magnetic resonance imaging-based hippocampus volume for prediction of dementia in mild cognitive impairment: Why does the measurement method matter so little?Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for AlzheiFunctional connectivity in cognitive control networks mitigates the impact of white matter lesions in the elderlyCortisol associated with hypometabolism across the Alzheimer's disease spectrumNormal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian RhythmEffects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)-study protocol for a randomized controlled trialDiagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera settingFDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot StudyPlasma cortisol is associated with cerebral hypometabolism across the Alzheimer's disease spectrumNormal Values of Renal Function measured with 99mTechnetium Mercaptoacetyltriglycine SPECT in Mice with Respect to Age, Sex and Circadian RhythmNigrostriatal Degeneration in the Cognitive Part of the Striatum in Parkinson Disease Is Associated With Frontomedial HypometabolismAutomatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristicsImpact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT
P50
Q35287222-A3422AE7-F59F-4312-8EFE-8CE23E5B1FE3Q39049291-B278402D-F403-4018-925B-F658B0CDCB18Q45165813-D2FA47E2-2A8B-4EBC-A74A-C643BC35B1A4Q47604596-6EF626D0-D499-491C-92A6-E5365EB0D9B4Q47894598-24F21883-042F-4734-91BB-4D6471FFDF58Q47963438-55472297-4E7F-4036-94C3-E22D105A00ADQ48309245-705EC87C-A69E-4295-AB83-0DAE27317447Q48550578-64FBC2FE-7EA3-4FC8-9FFB-47714CFB4AEFQ48693663-E4A595FA-8C6B-4661-A300-4EA6CC60B5B5Q48715994-978A42C0-02C4-4D61-9130-26A71627B949Q48753314-7C232F71-8E64-48D4-BB39-C0E1A0CEB21EQ48873936-754B8B00-39A3-4629-AFC9-BE26BE72D6D8Q49103178-C4C9E169-5258-4338-B1FD-76CDF1101C9CQ50059349-D24DCFB7-BD7F-446B-AF45-34080714425DQ50605716-36A8E5BA-DA7A-4C65-9FA5-71780C665583Q50608551-1BCB9A4E-8C36-4CB8-98B8-876FA9452A50Q51744764-42F08332-D1C2-453C-99EB-940E84345A64Q52804554-BE498191-3EEC-4134-ACD5-C927207BFD48Q52836541-2C4D517B-AD1F-4271-A4E4-71F9242008E4Q58109784-F9871312-E381-46C9-9E2E-60898C121089Q61228401-DED269FA-0F4D-44D1-9313-BD862091A573Q61901414-434E48B3-E8BE-4558-B795-958816649358Q64072604-1E26A5BC-4C99-46A8-A4D5-4AB08A5D4803Q64243835-CAD007B9-1448-4352-A421-A728EF03D6B2Q89933370-5C0C87F7-96B7-4D85-AAB2-6CB719F72454Q90097727-2021085F-CAE9-4A25-B029-5AFA2B2AB422Q90616924-9D8EA021-287F-4438-934A-59583B9E92DEQ92249981-1946D424-FE21-4732-A467-FB375BB0DEF9Q93039450-8B459A55-F2C9-40A5-A425-050C9532F3ECQ95272769-E5DE341E-C11E-4431-95EA-4FBAC282B999
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Catharina Lange
@ast
Catharina Lange
@en
Catharina Lange
@es
Catharina Lange
@nl
Catharina Lange
@sl
type
label
Catharina Lange
@ast
Catharina Lange
@en
Catharina Lange
@es
Catharina Lange
@nl
Catharina Lange
@sl
prefLabel
Catharina Lange
@ast
Catharina Lange
@en
Catharina Lange
@es
Catharina Lange
@nl
Catharina Lange
@sl
P106
P108
P21
P31
P3835
catharina-lange
P496
0000-0002-6745-8441
P569
2000-01-01T00:00:00Z